Veeva Systems Inc. (NYSE: VEEV) is a Technology company in the Software - Application industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 35.38 | EPS (ttm) | 5.76 | Insider Own | 8.35% | Shs Outstand | 162.44M | Perf Week | 9.42% |
| Market Cap | 33.10B | Forward P/E | 20.32 | EPS next Y | 10.03 | Insider Trans | -0.06% | Shs Float | 148.91M | Perf Month | 10.62% |
| Enterprise Value | 31.31B | PEG | 1.79 | EPS next Q | 2.22 | Inst Own | - | Short Float | 5.32% | Perf Quarter | 30.65% |
| Income | 936.81M | P/S | 9.97 | EPS this Y | 61.53% | Inst Trans | - | Short Ratio | 2.52 | Perf Half Y | -2.95% |
| Sales | 3.32B | P/B | 4.56 | EPS next Y | 10.69% | ROA | 10.31% | Short Interest | 7.92M | Perf YTD | -8.71% |
| Book/sh | - | P/C | 19.99 | EPS next 5Y | 12.45% | ROE | 13.36% | 52W High | 314.26 -34.37% | Perf Year | -28.97% |
| Cash/sh | - | P/FCF | 20.14 | EPS past 3/5Y | 21.94% 18.18% | ROIC | 9.73% | 52W Low | 149.85 37.64% | Perf 3Y | 1.39% |
| Dividend Est. | - | EV/EBITDA | 24.09 | Sales past 3/5Y | 14.03% 16.88% | Gross Margin | 74.95% | Volatility | 3.75% 3.70% | Perf 5Y | -38.82% |
| Dividend TTM | - | EV/Sales | 9.43 | EPS Y/Y TTM | 29.86% | Oper. Margin | 28.79% | ATR (14) | 8.12 | Perf 10Y | 462.15% |
| Dividend Ex-Date | - | Quick Ratio | 4.74 | Sales Y/Y TTM | 20.82% | Profit Margin | 28.37% | RSI (14) | 62.27 | Recom | 2.35 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.74 | EPS Q/Q | 28.74% | SMA20 | 5.19% | Beta | 0.90 | Target Price | 235.14 |
| Payout | 0.00% | Debt/Eq | 0.01 | Sales Q/Q | 16.34% | SMA50 | 14.44% | Rel Volume | 0.62 | Prev Close | 203.78 |
| Employees | 7,928 | LT Debt/Eq | 0.01 | Earnings | Sep 02 | SMA200 | -0.04% | Avg Volume | 3.04M | Price | 206.25 |
| IPO Date | Oct 16, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 4.70% 2.94% | Net Debt/EBITDA | -1.38 | Volume | 1,883,255 | Change | 1.21% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-22-26 | Initiated | Guggenheim | Buy | $252 → $232 |
| Jun-04-26 | Reiterated | BNP Paribas | $285 | |
| Jun-04-26 | Reiterated | Morgan Stanley | Equal Weight | $205 → $215 |
| Jun-04-26 | Reiterated | Robert W. Baird | $250 → $260 | |
| Jun-04-26 | Reiterated | Stifel Nicolaus | Buy | $320 → $230 |
| Jun-04-26 | Reiterated | Raymond James | Outperform | $340 → $225 |
| Jun-04-26 | Reiterated | BMO Capital | Market Perform | $175 |
| Jun-04-26 | Reiterated | Mizuho | Outperform | $295 → $270 |
| Jun-04-26 | Reiterated | Evercore ISI Group | In Line | $200 → $185 |
| Jun-04-26 | Reiterated | UBS | Neutral | $280 → $235 |
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 1/31/2026 | FY 2025 1/31/2025 | FY 2024 1/31/2024 | FY 2023 1/31/2023 | FY 2022 1/31/2022 | FY 2021 1/31/2021 | FY 2020 1/31/2020 | FY 2019 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,319 | 3,195 | 2,747 | 2,364 | 2,155 | 1,851 | 1,465 | 1,104 | 862 | |
| Cost of Goods Sold Incl. D&A | 830 | 782 | 700 | 677 | 609 | 504 | 409 | 303 | 245 | |
| Gross Profit | 2,488 | 2,413 | 2,047 | 1,686 | 1,546 | 1,347 | 1,056 | 801 | 617 | |
| Selling, General and Administrative Excl. Other | 740 | 730 | 662 | 628 | 566 | 460 | 384 | 305 | 235 | |
| Research and Development | 792 | 767 | 693 | 629 | 520 | 382 | 294 | 210 | 159 | |
| Other Operating Expense | 1 | 0 | 1 | 0 | 1 | 0 | 0 | -1 | 0 | |
| Operating Income | 956 | 916 | 691 | 429 | 459 | 505 | 378 | 286 | 223 | |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 287 | 278 | 228 | 159 | 50 | 7 | 16 | 27 | 16 | |
| Net Income Before Taxes | 1,244 | 1,195 | 919 | 588 | 509 | 512 | 394 | 314 | 239 | |
| Income Taxes | 302 | 286 | 205 | 62 | 21 | 85 | 14 | 13 | 9 | |
| Consolidated Net Income | 941 | 909 | 714 | 526 | 488 | 427 | 380 | 301 | 230 | |
| Net Income From Continuing Operations | 941 | 909 | 714 | 526 | 488 | 427 | 380 | 301 | 230 | |
| Net Income | 941 | 909 | 714 | 526 | 488 | 427 | 380 | 301 | 230 | |
| EPS (Recurring) | 5.76 | 5.55 | 4.41 | 3.27 | 3.14 | 2.79 | 2.52 | 2.04 | 1.59 | |
| EPS (Basic, Before Extraordinaries) | 5.76 | 5.55 | 4.41 | 3.27 | 3.14 | 2.79 | 2.52 | 2.04 | 1.59 | |
| EPS (Diluted) | 5.61 | 5.44 | 4.32 | 3.22 | 3.00 | 2.63 | 2.36 | 1.90 | 1.47 | |
| EBITDA | 1,299 | 1,245 | 959 | 621 | 538 | 540 | 407 | 306 | 237 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 36.76 | 37.49 | 54.00 | 64.41 | 56.85 | 89.94 | 117.14 | 77.16 | 74.19 | |
| Price To Sales Ratio | 10.13 | 10.47 | 13.76 | 14.13 | 12.27 | 19.55 | 28.49 | 19.65 | 18.22 | |
| Gross Margin | 74.96 | 75.52 | 74.52 | 71.32 | 71.74 | 72.77 | 72.08 | 72.55 | 71.58 | |
| Operating Margin | 28.80 | 28.67 | 25.15 | 18.15 | 21.30 | 27.28 | 25.80 | 25.91 | 25.87 | |
| Net Margin | 28.35 | 28.45 | 25.99 | 22.25 | 22.65 | 23.07 | 25.94 | 27.26 | 26.68 | |
| Shares Outstanding | 163 | 164 | 162 | 161 | 155 | 153 | 151 | 148 | 144 | |
| Market Capitalization | 33,619 | 33,443 | 37,788 | 33,393 | 26,435 | 36,191 | 41,742 | 21,698 | 15,705 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Schwenger Thomas D. | Pres. & Chief Customer Officer | Jul 16 '26 | Sale | 200.00 | 5,000 | 1,000,000 | 20,449 | Jul 20 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer | Jul 01 '26 | Option Exercise | 0.00 | 2,907 | 0 | 26,566 | Jul 06 |
| Zuppas Eleni Nitsa | President & Chief of Staff | Jul 01 '26 | Option Exercise | 0.00 | 2,180 | 0 | 33,418 | Jul 06 |
| Kondath Vipin | Chief Accounting Officer | Jul 01 '26 | Option Exercise | 0.00 | 167 | 0 | 2,843 | Jul 06 |
| Faddis Jonathan | SVP, Gen. Counsel, Secretary | Jul 01 '26 | Option Exercise | 0.00 | 1,635 | 0 | 10,160 | Jul 06 |
| Van Wagener Brian | Chief Financial Officer | Jul 01 '26 | Option Exercise | 0.00 | 1,635 | 0 | 10,018 | Jul 06 |
| Hung Priscilla | Director | Apr 30 '26 | Sale | 155.64 | 750 | 116,730 | 3,253 | May 04 |
| Hung Priscilla | Director | Apr 10 '26 | Sale | 153.50 | 750 | 115,125 | 4,003 | Apr 14 |
| Van Wagener Brian | Chief Financial Officer | Apr 01 '26 | Option Exercise | 0.00 | 872 | 0 | 8,753 | Apr 03 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer | Apr 01 '26 | Option Exercise | 0.00 | 2,043 | 0 | 24,247 | Apr 03 |
| Kondath Vipin | Chief Accounting Officer | Apr 01 '26 | Option Exercise | 0.00 | 2,603 | 0 | 3,530 | Apr 03 |
| Zuppas Eleni Nitsa | President & Chief of Staff | Apr 01 '26 | Option Exercise | 0.00 | 8,998 | 0 | 33,742 | Apr 03 |
| Faddis Jonathan | SVP, Gen. Counsel, Secretary | Apr 01 '26 | Option Exercise | 0.00 | 8,726 | 0 | 11,109 | Apr 03 |
| Schwenger Thomas D. | Pres. & Chief Customer Officer | Mar 05 '26 | Sale | 200.00 | 1,000 | 200,000 | 22,204 | Mar 09 |
| MOHR MARSHALL | Director | Mar 01 '26 | Option Exercise | 0.00 | 288 | 0 | 5,687 | Mar 03 |